AIVITA Biomedical Announces Case Report Suggesting Positive Collateral Benefits in Systemic Lupus Erythematosus Achieved Through the Use of Its Dendritic Cell Vaccine Kit
IRVINE, Calif. – Sep 21, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Advanced Therapies Europe
IRVINE, Calif. – Sep 5, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead Awarded OC50 Honor by The Orange County Business Journal
IRVINE, Calif. – Jul. 7, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote on AI in Healthcare at McKenna Institute Digital Innovation Summit
IRVINE, Calif. – Jun. 12, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Present at World Vaccine Congress
IRVINE, Calif. – Apr. 4, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Abundance360
IRVINE, Calif. – Mar. 20, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Chief Medical Officer Dr. Robert Dillman to Deliver Keynote at World Immunotherapy Congress
IRVINE, Calif. – Mar. 16, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead Joins Human Immunome Project Board of Directors
IRVINE, Calif. – Jan. 9, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
TAE Life Sciences and AIVITA Biomedical Announce Strategic Partnership to Advance Development of Target Boron Drugs for Glioblastoma
FOOTHILL RANCH, Calif.— January 4, 2023—TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy…
AIVITA Biomedical Chief Medical Officer Dr. Robert O. Dillman to Deliver Keynote and Chair Cancer Immunotherapy Track at World Vaccine and Immunotherapy Congress
IRVINE, Calif. – Nov. 29, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…